| abstract |
This invention relates to compounds of general Formula (I) nand pharmaceutically acceptable salts thereof, in which R 1 n, R 1a n, R 2 n, R 3 n, R 4 n, and (R 5 n) a nare as defined herein, to pharmaceutical compositions comprising such compounds and pharmaceutically acceptable salts thereof, and to methods of using such compounds, pharmaceutically acceptable salts and compositions for the treatment of abnormal cell growth, including cancer. |